Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide.

Donalisio M, Rusnati M, Cagno V, Civra A, Bugatti A, Giuliani A, Pirri G, Volante M, Papotti M, Landolfo S, Lembo D.

Antimicrob Agents Chemother. 2012 Oct;56(10):5278-88. doi: 10.1128/AAC.00771-12. Epub 2012 Jul 30.

2.

Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses.

Donalisio M, Rusnati M, Civra A, Bugatti A, Allemand D, Pirri G, Giuliani A, Landolfo S, Lembo D.

Antimicrob Agents Chemother. 2010 Oct;54(10):4290-9. doi: 10.1128/AAC.00471-10. Epub 2010 Jul 19.

3.

Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures.

Bon I, Lembo D, Rusnati M, Clò A, Morini S, Miserocchi A, Bugatti A, Grigolon S, Musumeci G, Landolfo S, Re MC, Gibellini D.

PLoS One. 2013 Oct 7;8(10):e76482. doi: 10.1371/journal.pone.0076482. eCollection 2013.

4.

Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.

Cagno V, Donalisio M, Civra A, Volante M, Veccelli E, Oreste P, Rusnati M, Lembo D.

Antimicrob Agents Chemother. 2014 Aug;58(8):4782-94. doi: 10.1128/AAC.02594-14. Epub 2014 Jun 9.

5.

Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers.

Luganini A, Nicoletto SF, Pizzuto L, Pirri G, Giuliani A, Landolfo S, Gribaudo G.

Antimicrob Agents Chemother. 2011 Jul;55(7):3231-9. doi: 10.1128/AAC.00149-11. Epub 2011 May 16.

6.

Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.

Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.

Antiviral Res. 2010 Mar;85(3):532-40. doi: 10.1016/j.antiviral.2010.01.003. Epub 2010 Jan 18.

7.

Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues.

Klimyte EM, Smith SE, Oreste P, Lembo D, Dutch RE.

J Virol. 2016 Sep 29;90(20):9237-50. doi: 10.1128/JVI.01362-16. Print 2016 Oct 15.

8.

Two novel fusion inhibitors of human respiratory syncytial virus.

Lundin A, Bergström T, Bendrioua L, Kann N, Adamiak B, Trybala E.

Antiviral Res. 2010 Dec;88(3):317-24. doi: 10.1016/j.antiviral.2010.10.004. Epub 2010 Oct 19.

PMID:
20965215
9.

Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.

Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA.

J Virol. 2007 Jan;81(1):261-71. Epub 2006 Oct 18.

10.

Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells.

Krusat T, Streckert HJ.

Arch Virol. 1997;142(6):1247-54.

PMID:
9229012
13.

A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.

Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02241-16. doi: 10.1128/AAC.02241-16. Print 2017 Apr.

14.

Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.

Wang KC, Chang JS, Lin LT, Chiang LC, Lin CC.

Am J Chin Med. 2012;40(5):1033-45. doi: 10.1142/S0192415X12500760.

PMID:
22928833
15.

GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.

Perron M, Stray K, Kinkade A, Theodore D, Lee G, Eisenberg E, Sangi M, Gilbert BE, Jordan R, Piedra PA, Toms GL, Mackman R, Cihlar T.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1264-73. doi: 10.1128/AAC.01497-15.

16.
17.

Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus.

Cui R, Wang Y, Wang L, Li G, Lan K, Altmeyer R, Zou G.

Antiviral Res. 2016 Aug;132:38-45. doi: 10.1016/j.antiviral.2016.05.010. Epub 2016 May 17.

PMID:
27210812
18.

Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms.

Douglas JL, Panis ML, Ho E, Lin KY, Krawczyk SH, Grant DM, Cai R, Swaminathan S, Chen X, Cihlar T.

Antimicrob Agents Chemother. 2005 Jun;49(6):2460-6.

19.

CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.

Chirkova T, Lin S, Oomens AG, Gaston KA, Boyoglu-Barnum S, Meng J, Stobart CC, Cotton CU, Hartert TV, Moore ML, Ziady AG, Anderson LJ.

J Gen Virol. 2015 Sep;96(9):2543-56. doi: 10.1099/vir.0.000218. Epub 2015 Jun 25.

20.

Supplemental Content

Support Center